MSK SPECTRUM Tumor Microenvironment Study (2022)
Overview
The MSK-SPECTRUM project (canonical cBioPortal studyId msk_spectrum_tme_2022) is a prospective cohort study at Memorial Sloan Kettering Cancer Center characterizing the tumor microenvironment in high-grade serous ovarian cancer (HGSOC). Genomic profiling performed with MSK-IMPACT targeted hybrid-capture sequencing. Reference genome: hg19. PMID:35764743
Composition
- Cancer type: HGSOC, predominantly stage III/IV.
- 36 prospective MSK-SPECTRUM patients contributed to the Boehm et al. 2022 multimodal cohort (as part of 296 total MSKCC cases). PMID:35764743
- MSK-IMPACT clinical sequencing used to infer HRD status via HRD-DDR gene variants (including BRCA1, BRCA2) and CCNE1 CNA, plus COSMIC SBS3 detection via SigMA. PMID:35764743
Assays / panels (linked)
- MSK-IMPACT targeted hybrid-capture sequencing (HRD-DDR gene variants, CCNE1 CNA).
Papers using this cohort
- PMID:35764743 — Boehm et al. 2022, Nature Cancer: 36 MSK-SPECTRUM patients (prospective arm) included as part of the 296-patient MSKCC cohort in the multimodal HGSOC late-fusion prognostic model.
Notable findings derived from this cohort
- HRD status inferred from MSK-IMPACT sequencing plus SigMA COSMIC SBS3 detection; 130 MSKCC cases had research consent for HRD calling (high-confidence SBS3 n=48, low-confidence n=30). PMID:35764743
- The full MSK-SPECTRUM + MSKCC cohort contributed CT imaging (adnexal and omental), H&E WSIs, and genomic data; the multimodal late-fusion model leveraged partial-data cases to avoid restricting training to the 114 patients with complete four-modality data. PMID:35764743
- Characterized the ovarian cancer tumor microenvironment using scRNA-seq and spatial transcriptomics across 36 HGSOC samples, revealing immune cell composition and stromal cell interactions PMID:36517593
Sources
- cBioPortal study: https://www.cbioportal.org/study/summary?id=msk_spectrum_tme_2022
- PMID:35764743 — Boehm et al. 2022, Nature Cancer.
This page was processed by crosslinker on 2026-05-05. - PMID:36517593
This page was processed by crosslinker on 2026-05-05.